The Most Dangerous Book: The Battle for James Joyce’s Ulysses (75 page)

, Oct. 5, 1929, p. 22.

and

Roth,

, p. 220, Roth Papers, Box 1, pp. 210–22.

1, no. 4 (June 1926).

Roth Papers, Box 1 Folder 10, p. 177.

June 13, 2012, email to me from Columbia University’s Office of the Registrar.

and

Cerf,

pp. 12–14.

2, no. 8 (June 1927).

See 1933 Cerf Diaries, Cerf Papers, Box 11.

and

Bennet Cerf Telegrams, Cerf Papers, Box 3 (March-April 1933).

24. TREPONEMA

August Suter, “Some Remembrances of Joyce” in Potts,

, p. 64.

JJ,

, p. 278.

Richard M. Kain, Carola Giedion-Welcker, and Maria Jolas, “An Interview with Carola Giedion-Welcker and Maria Jolas,”

11, no. 2 (1974), p. 96.

EP to JJ, Nov. 15, 1926,

, p. 228.

Weaver to JJ, Feb. 4, 1927, qtd. in Ell, p. 590.

JJ to Weaver, Feb. 1, 1927,

, p. 319.

, p. 217.

Ibid., p. 224.

Ibid., p. 274.

SB to JJ, April 12, 1927,

, pp. 319–20.

, p. 260.

Shloss,

, pp. 215–6.

Ibid., p. 189.

Ibid., p. 219.

Ell, p. 651.

JJ to Weaver, Oct. 21, 1934,

, pp. 349–51.

JJ qtd. in Shloss, p. 7.

JJ to Weaver, Nov. 11, 1932,

, p. 326.

Ell, p. 662.

Ell, p. 657; Shloss, pp. 232, 235.

Lucia Joyce qtd. in Shloss, p. 8.

Stuart Gilbert,

(Austin: University of Texas Press, 1993), pp. 47–48.

Ell, p. 607; Kevin Sullivan,

(Westport, Conn.: Greenwood Press, 1983), p. 58; Maddox,

, pp. 246–7.

JJ to SJ, Dec. 15, 1928,

, p. 184.

Ell, p 607.

JJ to Weaver, Dec. 2, 1928,

, 278.

Adolph Hoffmeister, “Portrait of Joyce” in Potts,

, pp. 128–9.

Maddox,

: p. 298.

Jacques Mercanton, “The Hours of James Joyce,” in Potts,

, p. 251.

JJ to Weaver, March 11, 1931,

, p. 303.

William Hinton,

(New York: Macmillan, 1936), pp. 61–134.

Hoffmeister, “Portrait of Joyce,” p. 132. See also Joyce’s short story, “The Sisters.”

T. C. Spoor et al., “Ocular Syphilis: Acute and Chronic,”

3 (1983), pp. 197–203; Curtis Margo and Latif Hamid, “Ocular Syphilis,”

37, no. 3 (Nov.-Dec. 1992), pp. 203–20.

JJ to Weaver, Sept. 20, 1928,

, p. 266.

Margo and Hamid, “Ocular Syphilis, p. 215.

and

Ibid., p. 205. See also Kathleen Ferris,

(Lexington: University of Kentucky Press, 1995), p. 81.

Weaver to Brewerton, Aug. 30, 1922, BL; JJ to Weaver telegram, Oct. 28, 1922, BL.

See, e.g., JJ to Weaver, Feb. 26, 1923, BL.

JJ to Weaver, Oct. 4, 1922,

, p. 67.

JJ to Weaver, March 18, 1930,

, p. 348; Lucia Joyce to Weaver, April 18, 1930(?), BL. Borsch and his assistant, Dr. Collinson, discussed the possibility of a “cure” for syphilitic eye troubles but exclude “the drug in question” because it “had a bad effect on the optic nerve.” That salvarsan is the drug in question is my inference. Lucia Joyce mentioned that the unnamed treatment has bad side effects for both the optic nerve and the retina. The date of her letter is Weaver’s estimate.

John Hinchman Stokes,

(Philadelphia: W. B. Saunders, 1936), p. 705–6; Hinton,

p. 218. Stokes notes a case of “violent rapidly progressing neuroretinitis,” and Hinton (citing Skirball and Thurman) notes optic neuritis in 2.7 percent of patients. See also Allen Brandt and J. W. Estes,

(New York: Oxford University Press, 1987).

JJ to Weaver, April 8, 1928,

, p. 175.

and

JJ to Weaver, Sept. 20, 1928,

, p. 266.

Arthur Foerster, “On Galyl, A Substitute for Salvarsan and Neosalvarsan,”

186 (Sept. 18, 1915), pp. 645–7; JJ Abraham, “Arseno-Therapy in Syphilis, with More Particular Reference to ‘Galyl’,”

1, no. 2776 (1914), pp. 582–3; Harold Spence, “Clinical Results of 1,000 Intravenous Injections of Galyl,”

186, no. 4815 (Dec. 11, 1915), pp. 1292–4; W. Lee Lewis, “Recent Developments in the Organic Chemistry of Arsenic,”

15, no. 1 (Jan. 1923), pp. 17–19.

L. W. Harrison, “The Treatment of Syphilis,”

40 (July 1917), p. 339.

JJ to Valery Larbaud, Oct. 7, 1928 [date uncertain],

, p. 182; JJ to Weaver, Oct. 23, 1928, BL; published in

, p. 270. This letter is misdated as Oct. 28 in

.

“An Experience of Galyl,”

, 104, no. 1–13 (1916), p. 328.

See Sir Gilbert Morgan,

(London: Longmans, Green, and Co., 1918).

Harrison, “Treatment,” p. 339.

JJ to Valery Larbaud, Oct. 7, 1928 [date uncertain],

, p. 182; JJ to Weaver, Oct. 23, 1928, BL; published in

, p. 270. In both letters, Joyce indicates he was receiving injections of arsenic and phosphorus for three weeks. Identifying this as galyl is my deduction after consulting available French and American pharmacopeias, national formularies and pharmaceutical dispensaries from the late 1920s. No other medication matches the description of “arsenic and phosphorus” injections, and galyl was used exclusively to treat syphilis. At least two doctors suggest precisely three weeks of injections. See, for example, Emile Brunor, “Notes on a New Organic Arsenic Preparation,”

20 (July 1914), p. 476.

JJ to Weaver, Oct. 23, 1928, BL; reprinted in

, p. 270.

Maddox,

p. 243.

J. B. Lyons maintains that Joyce suffered from an autoimmune affliction called Reiter’s disease. See J. B. Lyons,

(Dublin: Dolmen Press, 1973), and his more vehement article, “James Joyce: Steps Towards a Diagnosis,”

9, no. 3 (2000), pp. 294–306. As I have written elsewhere, the symptoms, progression and duration of Reiter’s simply do not match Joyce’s medical history. See my

article for a more detailed explanation. After ruling out Reiter’s syndrome, the only other reasonable differential diagnosis for Joyce’s recurrent anterior uveitis is a rare ailment called Behçet’s disease. My rough estimate is that the chances that Joyce had Behçet’s are three in a million. Behçet’s disease appears to be caused by both genetic and environmental components. See A. Gül, “Behçet’s Disease: An Update on the Pathogenesis,”

19, no. 24 (2001). It most commonly afflicts people from Turkey and countries along the ancient Silk Road to Japan. While the prevalence of Behçet’s among Irish people in the early twentieth century is impossible to determine (the disease was first identified in 1937), the prevalence in the United Kingdom in the latter half of the twentieth century is roughly five in one million. See C. C. Zouboulis, “Epidemiological Features of Adamantiades-Behçet’s Disease in Germany and in Europe,”